4//SEC Filing
Beneski Benjamin Machinas 4
Accession 0001737287-25-000094
CIK 0001737287other
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 4:09 PM ET
Size
5.5 KB
Accession
0001737287-25-000094
Insider Transaction Report
Form 4
Beneski Benjamin Machinas
SVP, Chief Technical Officer
Transactions
- Sale
Common Stock
2025-11-17$1.22/sh−786$959→ 217,721 total
Footnotes (2)
- [F1]Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.22 to $1.23, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Documents
Issuer
Allogene Therapeutics, Inc.
CIK 0001737287
Entity typeother
Related Parties
1- filerCIK 0002057918
Filing Metadata
- Form type
- 4
- Filed
- Nov 18, 7:00 PM ET
- Accepted
- Nov 19, 4:09 PM ET
- Size
- 5.5 KB